{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T18:23:06Z","timestamp":1785435786951,"version":"3.56.0"},"reference-count":90,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:00:00Z","timestamp":1777420800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:00:00Z","timestamp":1777420800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Deutsches Krebsforschungszentrum (DKFZ)"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Epigenet"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Estrogen receptor alpha (ER\u03b1)-positive luminal breast cancer is commonly treated with aromatase inhibitors (AI) to block estrogen signaling; however, resistance frequently develops, limiting therapy success.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      We observed that\n                      <jats:italic>GLYATL1<\/jats:italic>\n                      (Glycine-N-Acyltransferase Like 1) expression is upregulated in AI-resistant breast cancer cell models and in patients undergoing AI therapy, correlating with poorer survival. Here we demonstrate that GLYATL1 promotes resistance to estrogen deprivation by elevating succinate levels and altering epigenetic histone marks associated with active transcription. Knockdown or knockout of\n                      <jats:italic>GLYATL1<\/jats:italic>\n                      reverses these effects and reduces proliferation under estrogen-deprived conditions. Notably,\n                      <jats:italic>GLYATL1<\/jats:italic>\n                      expression is positively regulated by estrogen receptor alpha signaling, however, independently of estrogen.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>These findings reveal GLYATL1 as a metabolic and epigenetic mediator of endocrine therapy resistance, suggesting it as a potential target to overcome AI resistance in luminal breast cancer.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13148-026-02133-w","type":"journal-article","created":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T02:49:02Z","timestamp":1777430942000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["GLYATL1 is associated with metabolic and epigenetic changes and with endocrine resistance in luminal breast cancer"],"prefix":"10.1186","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7004-4795","authenticated-orcid":false,"given":"Janina","family":"M\u00fcller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5113-4047","authenticated-orcid":false,"given":"Emre","family":"Sofyali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7151-9913","authenticated-orcid":false,"given":"Luisa","family":"Schwarzm\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5821-9548","authenticated-orcid":false,"given":"Yael","family":"Aylon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6549-891X","authenticated-orcid":false,"given":"Eviatar","family":"Weizman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8350-2289","authenticated-orcid":false,"given":"Lisa","family":"Schlicker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3833-0032","authenticated-orcid":false,"given":"Simone","family":"Borgoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simin","family":"Oz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cole","family":"Stocker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Burmester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelika","family":"W\u00f6rner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Karolus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9948-4567","authenticated-orcid":false,"given":"Birgitta E.","family":"Michels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Heiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6049-2690","authenticated-orcid":false,"given":"Rainer","family":"Will","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica Rodrigues","family":"de Melo Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9383-8555","authenticated-orcid":false,"given":"Pavlo","family":"Lutsik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7915-412X","authenticated-orcid":false,"given":"Dieter","family":"Weichenhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3586-5050","authenticated-orcid":false,"given":"Ilse","family":"Hofmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2970-6739","authenticated-orcid":false,"given":"Nishanth Belugali","family":"Nataraj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4168-7884","authenticated-orcid":false,"given":"Yosef","family":"Yarden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7534-0785","authenticated-orcid":false,"given":"Luca","family":"Magnani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2554-3952","authenticated-orcid":false,"given":"Christoph","family":"Plass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8199-6422","authenticated-orcid":false,"given":"Almut","family":"Schulze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1150-9462","authenticated-orcid":false,"given":"Cindy","family":"K\u00f6rner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4311-7172","authenticated-orcid":false,"given":"Moshe","family":"Oren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4683-3174","authenticated-orcid":false,"given":"Stefan","family":"Wiemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,29]]},"reference":[{"issue":"3","key":"2133_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"2133_CR2","first-page":"10","volume":"75","author":"RL Siegel","year":"2025","unstructured":"Siegel RL, Kratzer TB, Giaquinto AN, Sung H, Jemal A. Cancer statistics, 2025. CA Cancer J Clin. 2025;75(1):10\u201345.","journal-title":"CA Cancer J Clin"},{"key":"2133_CR3","doi-asserted-by":"crossref","unstructured":"Orrantia-Borunda E, Anchondo-Nunez P, Acuna-Aguilar LE, Gomez-Valles FO, Ramirez-Valdespino CA. Subtypes of Breast Cancer. In: Mayrovitz HN, editor. Breast Cancer. Brisbane (AU)2022.","DOI":"10.36255\/exon-publications-breast-cancer-subtypes"},{"issue":"1","key":"2133_CR4","doi-asserted-by":"publisher","first-page":"R6","DOI":"10.1186\/bcr1639","volume":"9","author":"LK Dunnwald","year":"2007","unstructured":"Dunnwald LK, Rossing MA, Li CI. Hormone receptor status, tumor characteristics, and prognosis: a prospective cohort of breast cancer patients. Breast Cancer Res. 2007;9(1):R6.","journal-title":"Breast Cancer Res"},{"issue":"3","key":"2133_CR5","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.3390\/curroncol28030168","volume":"28","author":"S Andrahennadi","year":"2021","unstructured":"Andrahennadi S, Sami A, Manna M, Pauls M, Ahmed S. Current landscape of targeted therapy in hormone receptor-positive and HER2-negative breast cancer. Curr Oncol. 2021;28(3):1803\u201322.","journal-title":"Curr Oncol"},{"issue":"19","key":"2133_CR6","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1056\/NEJMoa1701830","volume":"377","author":"H Pan","year":"2017","unstructured":"Pan H, Gray R, Braybrooke J, Davies C, Taylor C, McGale P, et al. 20-year risks of breast-cancer recurrence after stopping endocrine therapy at 5 years. N Engl J Med. 2017;377(19):1836\u201346.","journal-title":"N Engl J Med"},{"issue":"16","key":"2133_CR7","doi-asserted-by":"publisher","first-page":"2630","DOI":"10.1200\/JCO.2008.18.8391","volume":"27","author":"J Baselga","year":"2009","unstructured":"Baselga J, Semiglazov V, van Dam P, Manikhas A, Bellet M, Mayordomo J, et al. Phase II randomized study of neoadjuvant everolimus plus letrozole compared with placebo plus letrozole in patients with estrogen receptor-positive breast cancer. J Clin Oncol. 2009;27(16):2630\u20137.","journal-title":"J Clin Oncol"},{"issue":"6","key":"2133_CR8","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1158\/1078-0432.CCR-21-2718","volume":"28","author":"MA Bergamino","year":"2022","unstructured":"Bergamino MA, Morani G, Parker J, Schuster EF, Leal MF, Lopez-Knowles E, et al. Impact of duration of neoadjuvant aromatase inhibitors on molecular expression profiles in estrogen receptor-positive breast cancers. Clin Cancer Res. 2022;28(6):1217\u201328.","journal-title":"Clin Cancer Res"},{"issue":"6","key":"2133_CR9","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1016\/j.celrep.2013.08.022","volume":"4","author":"S Li","year":"2013","unstructured":"Li S, Shen D, Shao J, Crowder R, Liu W, Prat A, et al. Endocrine-therapy-resistant ESR1 variants revealed by genomic characterization of breast-cancer-derived xenografts. Cell Rep. 2013;4(6):1116\u201330.","journal-title":"Cell Rep"},{"issue":"12","key":"2133_CR10","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1038\/ng.2822","volume":"45","author":"W Toy","year":"2013","unstructured":"Toy W, Shen Y, Won H, Green B, Sakr RA, Will M, et al. ESR1 ligand-binding domain mutations in hormone-resistant breast cancer. Nat Genet. 2013;45(12):1439\u201345.","journal-title":"Nat Genet"},{"issue":"2","key":"2133_CR11","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1158\/0008-5472.CAN-23-0184","volume":"84","author":"S Ahn","year":"2024","unstructured":"Ahn S, Park JH, Grimm SL, Piyarathna DWB, Samanta T, Putluri V, et al. Metabolomic rewiring promotes endocrine therapy resistance in breast cancer. Cancer Res. 2024;84(2):291\u2013304.","journal-title":"Cancer Res"},{"issue":"3","key":"2133_CR12","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1038\/s41594-023-01181-7","volume":"31","author":"J Achinger-Kawecka","year":"2024","unstructured":"Achinger-Kawecka J, Stirzaker C, Portman N, Campbell E, Chia KM, Du Q, et al. The potential of epigenetic therapy to target the 3D epigenome in endocrine-resistant breast cancer. Nat Struct Mol Biol. 2024;31(3):498\u2013512.","journal-title":"Nat Struct Mol Biol"},{"issue":"16","key":"2133_CR13","doi-asserted-by":"publisher","first-page":"E1490","DOI":"10.1073\/pnas.1219992110","volume":"110","author":"L Magnani","year":"2013","unstructured":"Magnani L, Stoeck A, Zhang X, Lanczky A, Mirabella AC, Wang TL, et al. Genome-wide reprogramming of the chromatin landscape underlies endocrine therapy resistance in breast cancer. Proc Natl Acad Sci USA. 2013;110(16):E1490\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"2133_CR14","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.ccell.2020.03.007","volume":"37","author":"A Marusyk","year":"2020","unstructured":"Marusyk A, Janiszewska M, Polyak K. Intratumor heterogeneity: the Rosetta Stone of therapy resistance. Cancer Cell. 2020;37(4):471\u201384.","journal-title":"Cancer Cell"},{"issue":"1","key":"2133_CR15","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/s41523-023-00604-4","volume":"9","author":"L Beumers","year":"2023","unstructured":"Beumers L, Vlachavas EI, Borgoni S, Schwarzmuller L, Penso-Dolfin L, Michels BE, et al. Clonal heterogeneity in ER+ breast cancer reveals the proteasome and PKC as potential therapeutic targets. NPJ Breast Cancer. 2023;9(1):97.","journal-title":"NPJ Breast Cancer"},{"issue":"4","key":"2133_CR16","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1016\/j.bbrc.2012.03.099","volume":"420","author":"M Matsuo","year":"2012","unstructured":"Matsuo M, Terai K, Kameda N, Matsumoto A, Kurokawa Y, Funase Y, et al. Designation of enzyme activity of glycine-N-acyltransferase family genes and depression of glycine-N-acyltransferase in human hepatocellular carcinoma. Biochem Biophys Res Commun. 2012;420(4):901\u20136.","journal-title":"Biochem Biophys Res Commun"},{"issue":"14","key":"2133_CR17","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1002\/pros.23887","volume":"79","author":"ML Eich","year":"2019","unstructured":"Eich ML, Chandrashekar DS, Rodriguez Pen AM, Robinson AD, Siddiqui J, Daignault-Newton S, et al. Characterization of glycine-N-acyltransferase like 1 (GLYATL1) in prostate cancer. Prostate. 2019;79(14):1629\u201339.","journal-title":"Prostate"},{"issue":"11","key":"2133_CR18","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1002\/mc.22425","volume":"55","author":"AK Nalla","year":"2016","unstructured":"Nalla AK, Williams TF, Collins CP, Rae DT, Trobridge GD. Lentiviral vector-mediated insertional mutagenesis screen identifies genes that influence androgen independent prostate cancer progression and predict clinical outcome. Mol Carcinog. 2016;55(11):1761\u201371.","journal-title":"Mol Carcinog"},{"issue":"11","key":"2133_CR19","doi-asserted-by":"publisher","first-page":"2484","DOI":"10.1002\/ijc.30680","volume":"140","author":"J Wang","year":"2017","unstructured":"Wang J, Shidfar A, Ivancic D, Ranjan M, Liu L, Choi MR, et al. Overexpression of lipid metabolism genes and PBX1 in the contralateral breasts of women with estrogen receptor-negative breast cancer. Int J Cancer. 2017;140(11):2484\u201397.","journal-title":"Int J Cancer"},{"key":"2133_CR20","doi-asserted-by":"publisher","first-page":"10044","DOI":"10.1038\/ncomms10044","volume":"6","author":"VT Nguyen","year":"2015","unstructured":"Nguyen VT, Barozzi I, Faronato M, Lombardo Y, Steel JH, Patel N, et al. Differential epigenetic reprogramming in response to specific endocrine therapies promotes cholesterol biosynthesis and cellular invasion. Nat Commun. 2015;6:10044.","journal-title":"Nat Commun"},{"key":"2133_CR21","doi-asserted-by":"crossref","unstructured":"Borgoni S, Sofyali E, Soleimani M, Wilhelm H, Muller-Decker K, Will R, et al. Time-resolved profiling reveals ATF3 as a novel mediator of endocrine resistance in breast cancer. Cancers (Basel). 2020;12(10).","DOI":"10.3390\/cancers12102918"},{"issue":"D1","key":"2133_CR22","doi-asserted-by":"publisher","first-page":"D1331","DOI":"10.1093\/nar\/gkaf1250","volume":"54","author":"J Casper","year":"2026","unstructured":"Casper J, Speir ML, Raney BJ, Perez G, Nassar LR, Lee CM, et al. The UCSC Genome Browser database: 2026 update. Nucleic Acids Res. 2026;54(D1):D1331\u20135.","journal-title":"Nucleic Acids Res"},{"issue":"4","key":"2133_CR23","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.molcel.2010.05.004","volume":"38","author":"S Heinz","year":"2010","unstructured":"Heinz S, Benner C, Spann N, Bertolino E, Lin YC, Laslo P, et al. Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. Mol Cell. 2010;38(4):576\u201389.","journal-title":"Mol Cell"},{"issue":"4","key":"2133_CR24","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/nmeth.1923","volume":"9","author":"B Langmead","year":"2012","unstructured":"Langmead B, Salzberg SL. Fast gapped-read alignment with Bowtie 2. Nat Methods. 2012;9(4):357\u20139.","journal-title":"Nat Methods"},{"issue":"16","key":"2133_CR25","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1093\/bioinformatics\/btp352","volume":"25","author":"H Li","year":"2009","unstructured":"Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, Homer N, et al. The Sequence Alignment\/Map format and SAMtools. Bioinformatics. 2009;25(16):2078\u20139.","journal-title":"Bioinformatics"},{"issue":"12","key":"2133_CR26","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1093\/bioinformatics\/btv098","volume":"31","author":"A Tarasov","year":"2015","unstructured":"Tarasov A, Vilella AJ, Cuppen E, Nijman IJ, Prins P. Sambamba: fast processing of NGS alignment formats. Bioinformatics. 2015;31(12):2032\u20134.","journal-title":"Bioinformatics"},{"issue":"1","key":"2133_CR27","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S, et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics. 2013;29(1):15\u201321.","journal-title":"Bioinformatics"},{"issue":"2","key":"2133_CR28","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1093\/bioinformatics\/btu638","volume":"31","author":"S Anders","year":"2015","unstructured":"Anders S, Pyl PT, Huber W. HTSeq--a Python framework to work with high-throughput sequencing data. Bioinformatics. 2015;31(2):166\u20139.","journal-title":"Bioinformatics"},{"issue":"12","key":"2133_CR29","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15(12):550.","journal-title":"Genome Biol"},{"issue":"W1","key":"2133_CR30","doi-asserted-by":"publisher","first-page":"W160","DOI":"10.1093\/nar\/gkw257","volume":"44","author":"F Ramirez","year":"2016","unstructured":"Ramirez F, Ryan DP, Gruning B, Bhardwaj V, Kilpert F, Richter AS, et al. deepTools2: a next generation web server for deep-sequencing data analysis. Nucleic Acids Res. 2016;44(W1):W160\u20135.","journal-title":"Nucleic Acids Res"},{"key":"2133_CR31","doi-asserted-by":"crossref","unstructured":"Buenrostro JD, Wu B, Chang HY, Greenleaf WJ. ATAC-seq: A Method for Assaying Chromatin Accessibility Genome-Wide. Current protocols in molecular biology \/ edited by Frederick M Ausubel [et al]. 2015;109:21 9 1- 9 9.","DOI":"10.1002\/0471142727.mb2129s109"},{"issue":"9","key":"2133_CR32","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2008-9-9-r137","volume":"9","author":"Y Zhang","year":"2008","unstructured":"Zhang Y, Liu T, Meyer CA, Eeckhoute J, Johnson DS, Bernstein BE, et al. Model-based analysis of ChIP-Seq (MACS). Genome Biol. 2008;9(9):R137.","journal-title":"Genome Biol"},{"issue":"1","key":"2133_CR33","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","volume":"26","author":"MD Robinson","year":"2010","unstructured":"Robinson MD, McCarthy DJ, Smyth GK. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics. 2010;26(1):139\u201340.","journal-title":"Bioinformatics"},{"key":"2133_CR34","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-11-237","volume":"11","author":"LJ Zhu","year":"2010","unstructured":"Zhu LJ, Gazin C, Lawson ND, Pages H, Lin SM, Lapointe DS, et al. ChIPpeakAnno: a Bioconductor package to annotate ChIP-seq and ChIP-chip data. BMC Bioinformatics. 2010;11:237.","journal-title":"BMC Bioinformatics"},{"issue":"1","key":"2133_CR35","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s13059-019-1664-9","volume":"20","author":"F Muller","year":"2019","unstructured":"Muller F, Scherer M, Assenov Y, Lutsik P, Walter J, Lengauer T, et al. RnBeads 2.0: comprehensive analysis of DNA methylation data. Genome Biol. 2019;20(1):55.","journal-title":"Genome Biol"},{"key":"2133_CR36","doi-asserted-by":"crossref","unstructured":"ORFeome Collaboration. The ORFeome Collaboration: a genome-scale human ORF-clone resource. Nat Methods. 2016;13(3):191\u20132.","DOI":"10.1038\/nmeth.3776"},{"issue":"Pt 3","key":"2133_CR37","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1111\/j.1365-2818.2006.01706.x","volume":"224","author":"S Bolte","year":"2006","unstructured":"Bolte S, Cordelieres FP. A guided tour into subcellular colocalization analysis in light microscopy. J Microsc. 2006;224(Pt 3):213\u201332.","journal-title":"J Microsc"},{"issue":"5259","key":"2133_CR38","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1038\/227680a0","volume":"227","author":"UK Laemmli","year":"1970","unstructured":"Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970;227(5259):680\u20135.","journal-title":"Nature"},{"issue":"1","key":"2133_CR39","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini Y, Hochberg Y. Controlling the false discovery rate - a practical and powerful approach to multiple testing. J R Stat Soc B Stat Methodol. 1995;57(1):289\u2013300.","journal-title":"J R Stat Soc B Stat Methodol"},{"key":"2133_CR40","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/978-1-4939-9236-2_19","volume":"1978","author":"S Agrawal","year":"2019","unstructured":"Agrawal S, Kumar S, Sehgal R, George S, Gupta R, Poddar S, et al. El-MAVEN: a fast, robust, and user-friendly mass spectrometry data processing engine for metabolomics. Methods Mol Biol. 2019;1978:301\u201321.","journal-title":"Methods Mol Biol"},{"issue":"2","key":"2133_CR41","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1002\/cyto.a.23926","volume":"97","author":"CB Bagwell","year":"2020","unstructured":"Bagwell CB, Inokuma M, Hunsberger B, Herbert D, Bray C, Hill B, et al. Automated data cleanup for mass cytometry. Cytometry A. 2020;97(2):184\u201398.","journal-title":"Cytometry A"},{"key":"2133_CR42","doi-asserted-by":"publisher","first-page":"748","DOI":"10.12688\/f1000research.11622.1","volume":"6","author":"M Nowicka","year":"2017","unstructured":"Nowicka M, Krieg C, Crowell HL, Weber LM, Hartmann FJ, Guglietta S, et al. CyTOF workflow: differential discovery in high-throughput high-dimensional cytometry datasets. F1000Res. 2017;6:748.","journal-title":"F1000Res"},{"issue":"4","key":"2133_CR43","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 2001;25(4):402\u20138.","journal-title":"Methods"},{"issue":"7","key":"2133_CR44","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43(7):e47.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"2133_CR45","doi-asserted-by":"publisher","first-page":"vbac016","DOI":"10.1093\/bioadv\/vbac016","volume":"2","author":"IMP Badia","year":"2022","unstructured":"Badia IMP, Velez Santiago J, Braunger J, Geiss C, Dimitrov D, Muller-Dott S, et al. decoupleR: ensemble of computational methods to infer biological activities from omics data. Bioinform Adv. 2022;2(1):vbac016.","journal-title":"Bioinform Adv."},{"issue":"8","key":"2133_CR46","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1101\/gr.240663.118","volume":"29","author":"L Garcia-Alonso","year":"2019","unstructured":"Garcia-Alonso L, Holland CH, Ibrahim MM, Turei D, Saez-Rodriguez J. Benchmark and integration of resources for the estimation of human transcription factor activities. Genome Res. 2019;29(8):1363\u201375.","journal-title":"Genome Res"},{"issue":"20","key":"2133_CR47","doi-asserted-by":"publisher","first-page":"10934","DOI":"10.1093\/nar\/gkad841","volume":"51","author":"S Muller-Dott","year":"2023","unstructured":"Muller-Dott S, Tsirvouli E, Vazquez M, Ramirez Flores RO, Badia IMP, Fallegger R, et al. Expanding the coverage of regulons from high-confidence prior knowledge for accurate estimation of transcription factor activities. Nucleic Acids Res. 2023;51(20):10934\u201349.","journal-title":"Nucleic Acids Res"},{"issue":"43","key":"2133_CR48","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005;102(43):15545\u201350.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"2133_CR49","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1039\/C5MB00663E","volume":"12","author":"G Yu","year":"2016","unstructured":"Yu G, He QY. ReactomePA: an R\/Bioconductor package for reactome pathway analysis and visualization. Mol Biosyst. 2016;12(2):477\u20139.","journal-title":"Mol Biosyst"},{"issue":"D1","key":"2133_CR50","doi-asserted-by":"publisher","first-page":"D672","DOI":"10.1093\/nar\/gkad1025","volume":"52","author":"M Milacic","year":"2024","unstructured":"Milacic M, Beavers D, Conley P, Gong C, Gillespie M, Griss J, et al. The reactome pathway knowledgebase 2024. Nucleic Acids Res. 2024;52(D1):D672\u20138.","journal-title":"Nucleic Acids Res"},{"issue":"19","key":"2133_CR51","doi-asserted-by":"publisher","first-page":"5371","DOI":"10.1158\/0008-5472.CAN-14-0620","volume":"74","author":"LM Arthur","year":"2014","unstructured":"Arthur LM, Turnbull AK, Webber VL, Larionov AA, Renshaw L, Kay C, et al. Molecular changes in lobular breast cancers in response to endocrine therapy. Cancer Res. 2014;74(19):5371\u20136.","journal-title":"Cancer Res"},{"issue":"33","key":"2133_CR52","doi-asserted-by":"publisher","first-page":"13820","DOI":"10.1073\/pnas.0905718106","volume":"106","author":"CJ Creighton","year":"2009","unstructured":"Creighton CJ, Li X, Landis M, Dixon JM, Neumeister VM, Sjolund A, et al. Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features. Proc Natl Acad Sci U S A. 2009;106(33):13820\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2133_CR53","doi-asserted-by":"crossref","unstructured":"Cancer Genome Atlas N. Comprehensive molecular portraits of human breast tumours. Nature. 2012;490(7418):61\u201370.","DOI":"10.1038\/nature11412"},{"issue":"1","key":"2133_CR54","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1186\/s13046-022-02380-8","volume":"41","author":"X Li","year":"2022","unstructured":"Li X, Michels BE, Tosun OE, Jung J, Kappes J, Ibing S, et al. 5\u2019isomiR-183-5p|+2 elicits tumor suppressor activity in a negative feedback loop with E2F1. J Exp Clin Cancer Res. 2022;41(1):190.","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"2133_CR55","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s13059-020-1949-z","volume":"21","author":"CH Holland","year":"2020","unstructured":"Holland CH, Tanevski J, Perales-Paton J, Gleixner J, Kumar MP, Mereu E, et al. Robustness and applicability of transcription factor and pathway analysis tools on single-cell RNA-seq data. Genome Biol. 2020;21(1):36.","journal-title":"Genome Biol"},{"issue":"44","key":"2133_CR56","doi-asserted-by":"publisher","first-page":"30474","DOI":"10.1074\/jbc.M109.036665","volume":"284","author":"SY Bu","year":"2009","unstructured":"Bu SY, Mashek MT, Mashek DG. Suppression of long chain acyl-CoA synthetase 3 decreases hepatic de novo fatty acid synthesis through decreased transcriptional activity. J Biol Chem. 2009;284(44):30474\u201383.","journal-title":"J Biol Chem"},{"issue":"2","key":"2133_CR57","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1128\/MCB.25.2.612-620.2005","volume":"25","author":"O Rozenblatt-Rosen","year":"2005","unstructured":"Rozenblatt-Rosen O, Hughes CM, Nannepaga SJ, Shanmugam KS, Copeland TD, Guszczynski T, et al. The parafibromin tumor suppressor protein is part of a human Paf1 complex. Mol Cell Biol. 2005;25(2):612\u201320.","journal-title":"Mol Cell Biol"},{"key":"2133_CR58","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.semcdb.2019.04.013","volume":"98","author":"E Dalla Pozza","year":"2020","unstructured":"Dalla Pozza E, Dando I, Pacchiana R, Liboi E, Scupoli MT, Donadelli M, et al. Regulation of succinate dehydrogenase and role of succinate in cancer. Semin Cell Dev Biol. 2020;98:4\u201314.","journal-title":"Semin Cell Dev Biol"},{"issue":"4","key":"2133_CR59","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1042\/BST20160099","volume":"44","author":"G Laurenti","year":"2016","unstructured":"Laurenti G, Tennant DA. Isocitrate dehydrogenase (IDH), succinate dehydrogenase (SDH), fumarate hydratase (FH): three players for one phenotype in cancer? Biochem Soc Trans. 2016;44(4):1111\u20136.","journal-title":"Biochem Soc Trans"},{"issue":"5","key":"2133_CR60","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/j.cmet.2016.09.015","volume":"24","author":"SP Burr","year":"2016","unstructured":"Burr SP, Costa AS, Grice GL, Timms RT, Lobb IT, Freisinger P, et al. Mitochondrial protein lipoylation and the 2-oxoglutarate dehydrogenase complex controls hif1alpha stability in aerobic conditions. Cell Metab. 2016;24(5):740\u201352.","journal-title":"Cell Metab"},{"issue":"1","key":"2133_CR61","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s12929-022-00878-z","volume":"29","author":"CC Kuo","year":"2022","unstructured":"Kuo CC, Wu JY, Wu KK. Cancer-derived extracellular succinate: a driver of cancer metastasis. J Biomed Sci. 2022;29(1):93.","journal-title":"J Biomed Sci"},{"issue":"12","key":"2133_CR62","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1101\/gad.191056.112","volume":"26","author":"M Xiao","year":"2012","unstructured":"Xiao M, Yang H, Xu W, Ma S, Lin H, Zhu H, et al. Inhibition of alpha-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors. Genes Dev. 2012;26(12):1326\u201338.","journal-title":"Genes Dev"},{"issue":"1","key":"2133_CR63","doi-asserted-by":"publisher","first-page":"7199","DOI":"10.1038\/s41467-022-34863-9","volume":"13","author":"Y Aylon","year":"2022","unstructured":"Aylon Y, Furth N, Mallel G, Friedlander G, Nataraj NB, Dong M, et al. Breast cancer plasticity is restricted by a LATS1-NCOR1 repressive axis. Nat Commun. 2022;13(1):7199.","journal-title":"Nat Commun"},{"issue":"14","key":"2133_CR64","doi-asserted-by":"publisher","first-page":"2696","DOI":"10.1016\/j.molcel.2022.05.023","volume":"82","author":"N Harpaz","year":"2022","unstructured":"Harpaz N, Mittelman T, Beresh O, Griess O, Furth N, Salame TM, et al. Single-cell epigenetic analysis reveals principles of chromatin states in H33\u2013K27M gliomas. Mol Cell. 2022;82(14):2696\u2013713.","journal-title":"Mol Cell"},{"issue":"7951","key":"2133_CR65","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1038\/s41586-023-05780-8","volume":"615","author":"H Wang","year":"2023","unstructured":"Wang H, Fan Z, Shliaha PV, Miele M, Hendrickson RC, Jiang X, et al. H3K4me3 regulates RNA polymerase II promoter-proximal pause-release. Nature. 2023;615(7951):339\u201348.","journal-title":"Nature"},{"key":"2133_CR66","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.01632","volume":"3","author":"V Di Cerbo","year":"2014","unstructured":"Di Cerbo V, Mohn F, Ryan DP, Montellier E, Kacem S, Tropberger P, et al. Acetylation of histone H3 at lysine 64 regulates nucleosome dynamics and facilitates transcription. Elife. 2014;3:e01632.","journal-title":"Elife"},{"issue":"3","key":"2133_CR67","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.chembiol.2017.02.006","volume":"24","author":"A Tumber","year":"2017","unstructured":"Tumber A, Nuzzi A, Hookway ES, Hatch SB, Velupillai S, Johansson C, et al. Potent and selective KDM5 inhibitor stops cellular demethylation of H3K4me3 at transcription start sites and proliferation of MM1S myeloma cells. Cell Chem Biol. 2017;24(3):371\u201380.","journal-title":"Cell Chem Biol"},{"issue":"1","key":"2133_CR68","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1186\/s13148-021-01187-2","volume":"13","author":"C Xiao","year":"2021","unstructured":"Xiao C, Fan T, Tian H, Zheng Y, Zhou Z, Li S, et al. H3K36 trimethylation-mediated biological functions in cancer. Clin Epigenetics. 2021;13(1):199.","journal-title":"Clin Epigenetics"},{"issue":"4","key":"2133_CR69","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1677\/erc.1.01257","volume":"13","author":"B Kuske","year":"2006","unstructured":"Kuske B, Naughton C, Moore K, Macleod KG, Miller WR, Clarke R, et al. Endocrine therapy resistance can be associated with high estrogen receptor alpha (ERalpha) expression and reduced ERalpha phosphorylation in breast cancer models. Endocr Relat Cancer. 2006;13(4):1121\u201333.","journal-title":"Endocr Relat Cancer"},{"key":"2133_CR70","doi-asserted-by":"crossref","unstructured":"Moore JE, Pratt HE, Fan K, Phalke N, Fisher J, Elhajjajy SI, et al. An expanded registry of candidate cis-regulatory elements. Nature. 2026.","DOI":"10.1038\/s41586-025-09909-9"},{"issue":"8","key":"2133_CR71","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1194\/jlr.M100417-JLR200","volume":"43","author":"M Amemiya-Kudo","year":"2002","unstructured":"Amemiya-Kudo M, Shimano H, Hasty AH, Yahagi N, Yoshikawa T, Matsuzaka T, et al. Transcriptional activities of nuclear SREBP-1a, -1c, and -2 to different target promoters of lipogenic and cholesterogenic genes. J Lipid Res. 2002;43(8):1220\u201335.","journal-title":"J Lipid Res"},{"issue":"33","key":"2133_CR72","doi-asserted-by":"publisher","first-page":"11651","DOI":"10.1073\/pnas.0505575102","volume":"102","author":"J Laganiere","year":"2005","unstructured":"Laganiere J, Deblois G, Lefebvre C, Bataille AR, Robert F, Giguere V. From the Cover: Location analysis of estrogen receptor alpha target promoters reveals that FOXA1 defines a domain of the estrogen response. Proc Natl Acad Sci USA. 2005;102(33):11651\u20136.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"2133_CR73","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/ng.730","volume":"43","author":"A Hurtado","year":"2011","unstructured":"Hurtado A, Holmes KA, Ross-Innes CS, Schmidt D, Carroll JS. FOXA1 is a key determinant of estrogen receptor function and endocrine response. Nature Genet. 2011;43(1):27\u201333.","journal-title":"Nature Genet"},{"issue":"12","key":"2133_CR74","first-page":"4595","volume":"36","author":"M Lippman","year":"1976","unstructured":"Lippman M, Bolan G, Huff K. The effects of estrogens and antiestrogens on hormone-responsive human breast cancer in long-term tissue culture. Cancer Res. 1976;36(12):4595\u2013601.","journal-title":"Cancer Res"},{"issue":"1","key":"2133_CR75","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/s41467-019-13668-3","volume":"11","author":"I Martinez-Reyes","year":"2020","unstructured":"Martinez-Reyes I, Chandel NS. Mitochondrial TCA cycle metabolites control physiology and disease. Nat Commun. 2020;11(1):102.","journal-title":"Nat Commun"},{"issue":"18 Pt B","key":"2133_CR76","doi-asserted-by":"publisher","first-page":"3081","DOI":"10.1016\/j.jmb.2018.06.048","volume":"430","author":"T Laukka","year":"2018","unstructured":"Laukka T, Myllykoski M, Looper RE, Koivunen P. Cancer-associated 2-oxoglutarate analogues modify histone methylation by inhibiting histone lysine demethylases. J Mol Biol. 2018;430(18 Pt B):3081\u201392.","journal-title":"J Mol Biol"},{"issue":"8","key":"2133_CR77","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1007\/s00432-020-03265-z","volume":"146","author":"L Berger","year":"2020","unstructured":"Berger L, Kolben T, Meister S, Kolben TM, Schmoeckel E, Mayr D, et al. Expression of H3K4me3 and H3K9ac in breast cancer. J Cancer Res Clin Oncol. 2020;146(8):2017\u201327.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"5","key":"2133_CR78","doi-asserted-by":"publisher","first-page":"5094","DOI":"10.18632\/oncotarget.6922","volume":"7","author":"TL Messier","year":"2016","unstructured":"Messier TL, Gordon JA, Boyd JR, Tye CE, Browne G, Stein JL, et al. Histone H3 lysine 4 acetylation and methylation dynamics define breast cancer subtypes. Oncotarget. 2016;7(5):5094\u2013109.","journal-title":"Oncotarget"},{"key":"2133_CR79","doi-asserted-by":"crossref","unstructured":"Kao HY, Pai CP, Wang H, Agarwal N, Adams J, Liu Z, et al. The PML1-WDR5 axis regulates H3K4me3 marks and promotes stemness of estrogen receptor-positive breast cancer. Res Sq. 2023.","DOI":"10.21203\/rs.3.rs-3266720\/v1"},{"issue":"1","key":"2133_CR80","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1038\/s41467-019-14098-x","volume":"11","author":"J Achinger-Kawecka","year":"2020","unstructured":"Achinger-Kawecka J, Valdes-Mora F, Luu PL, Giles KA, Caldon CE, Qu W, et al. Epigenetic reprogramming at estrogen-receptor binding sites alters 3D chromatin landscape in endocrine-resistant breast cancer. Nat Commun. 2020;11(1):320.","journal-title":"Nat Commun"},{"issue":"3","key":"2133_CR81","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0262378","volume":"17","author":"A Bommi-Reddy","year":"2022","unstructured":"Bommi-Reddy A, Park-Chouinard S, Mayhew DN, Terzo E, Hingway A, Steinbaugh MJ, et al. CREBBP\/EP300 acetyltransferase inhibition disrupts FOXA1-bound enhancers to inhibit the proliferation of ER+ breast cancer cells. PLoS ONE. 2022;17(3):e0262378.","journal-title":"PLoS ONE"},{"issue":"10","key":"2133_CR82","doi-asserted-by":"publisher","first-page":"4164","DOI":"10.1210\/endo.139.10.6229","volume":"139","author":"MH Jeng","year":"1998","unstructured":"Jeng MH, Shupnik MA, Bender TP, Westin EH, Bandyopadhyay D, Kumar R, et al. Estrogen receptor expression and function in long-term estrogen-deprived human breast cancer cells. Endocrinology. 1998;139(10):4164\u201374.","journal-title":"Endocrinology"},{"issue":"19","key":"2133_CR83","doi-asserted-by":"publisher","first-page":"3408","DOI":"10.1038\/s41388-021-01782-w","volume":"40","author":"NA Traphagen","year":"2021","unstructured":"Traphagen NA, Hosford SR, Jiang A, Marotti JD, Brauer BL, Demidenko E, et al. High Estrogen Receptor Alpha activation confers resistance to estrogen deprivation and is required for therapeutic response to estrogen in breast cancer. Oncogene. 2021;40(19):3408\u201321.","journal-title":"Oncogene"},{"issue":"2","key":"2133_CR84","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbagrm.2022.194787","volume":"1865","author":"J Pardeshi","year":"2022","unstructured":"Pardeshi J, McCormack N, Gu L, Ryan CS, Schroder M. DDX3X functionally and physically interacts with Estrogen Receptor-alpha. Biochim Biophys Acta Gene Regul Mech. 2022;1865(2):194787.","journal-title":"Biochim Biophys Acta Gene Regul Mech"},{"issue":"8","key":"2133_CR85","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1038\/s42255-024-01104-w","volume":"6","author":"Y Qiu","year":"2024","unstructured":"Qiu Y, Stamatatos OT, Hu Q, Ruiter Swain J, Russo S, Sann A, et al. The unique catalytic properties of PSAT1 mediate metabolic adaptation to glutamine blockade. Nat Metab. 2024;6(8):1529\u201348.","journal-title":"Nat Metab"},{"issue":"8","key":"2133_CR86","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.tibs.2010.05.003","volume":"35","author":"DR Wise","year":"2010","unstructured":"Wise DR, Thompson CB. Glutamine addiction: a new therapeutic target in cancer. Trends Biochem Sci. 2010;35(8):427\u201333.","journal-title":"Trends Biochem Sci"},{"issue":"15","key":"2133_CR87","doi-asserted-by":"publisher","first-page":"3248","DOI":"10.1158\/1078-0432.CCR-22-0061","volume":"28","author":"CH Lee","year":"2022","unstructured":"Lee CH, Motzer R, Emamekhoo H, Matrana M, Percent I, Hsieh JJ, et al. Telaglenastat plus Everolimus in advanced renal cell carcinoma: a randomized, double-blinded, placebo-controlled, Phase II ENTRATA trial. Clin Cancer Res. 2022;28(15):3248\u201355.","journal-title":"Clin Cancer Res"},{"issue":"D1","key":"2133_CR88","doi-asserted-by":"publisher","first-page":"D543","DOI":"10.1093\/nar\/gkae1011","volume":"53","author":"Y Perez-Riverol","year":"2025","unstructured":"Perez-Riverol Y, Bandla C, Kundu DJ, Kamatchinathan S, Bai J, Hewapathirana S, et al. The PRIDE database at 20 years: 2025 update. Nucleic Acids Res. 2025;53(D1):D543\u201353.","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"2133_CR89","doi-asserted-by":"publisher","first-page":"D316","DOI":"10.1093\/nar\/gkab996","volume":"50","author":"F Hammal","year":"2022","unstructured":"Hammal F, de Langen P, Bergon A, Lopez F, Ballester B. ReMap 2022: a database of Human, Mouse, Drosophila and Arabidopsis regulatory regions from an integrative analysis of DNA-binding sequencing experiments. Nucleic Acids Res. 2022;50(D1):D316\u201325.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"2133_CR90","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/nbt.1754","volume":"29","author":"JT Robinson","year":"2011","unstructured":"Robinson JT, Thorvaldsdottir H, Winckler W, Guttman M, Lander ES, Getz G, et al. Integrative genomics viewer. Nat Biotechnol. 2011;29(1):24\u20136.","journal-title":"Nat Biotechnol"}],"updated-by":[{"DOI":"10.1186\/s13148-026-02203-z","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T00:00:00Z","timestamp":1783641600000}}],"container-title":["Clinical Epigenetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13148-026-02133-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13148-026-02133-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13148-026-02133-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T07:01:53Z","timestamp":1783666913000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13148-026-02133-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,29]]},"references-count":90,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2133"],"URL":"https:\/\/doi.org\/10.1186\/s13148-026-02133-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2025.10.17.682994","asserted-by":"object"}]},"ISSN":["1868-7083"],"issn-type":[{"value":"1868-7083","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,29]]},"assertion":[{"value":"17 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2026","order":6,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":7,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original online version of this article was revised: Competing interest section has been updated in the article PDF.","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2026","order":9,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":10,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":11,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s13148-026-02203-z","URL":"https:\/\/doi.org\/10.1186\/s13148-026-02203-z","order":12,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Stefan Wiemann is an Associate Editor of Clinical Epigenetics. To ensure an independent and unbiased review process, Stefan Wiemann had no involvement in the peer review, editorial assessment, or decision-making for this manuscript. The remaining authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"76"}}